| Identification of potential N-substituted 5-benzylidenethiazolidine-2, 4‑dione derivatives as α-amylase inhibitors: Computational cum synthetic studies S Gupta, GS Baweja, GD Gupta, V Asati Journal of Molecular Structure 1287, 135596, 2023 | 9 | 2023 |
| Field and atom-based 3D-QSAR models of chromone (1-benzopyran-4-one) derivatives as MAO inhibitors M Saha, S Gupta, S Dhiman, V Asati, A Ali, A Ali Journal of Biomolecular Structure and Dynamics 41 (21), 12171-12185, 2023 | 8 | 2023 |
| Recent updates on structural insights of MAO-B inhibitors: A review on target-based approach GS Baweja, S Gupta, B Kumar, P Patel, V Asati Molecular Diversity, 1-23, 2023 | 6 | 2023 |
| Integrated fragment-based drug design and virtual screening techniques for exploring the antidiabetic potential of thiazolidine-2, 4-diones: Design, synthesis and in vivo studies S Gupta, GS Baweja, S Singh, M Irani, R Singh, V Asati European Journal of Medicinal Chemistry 261, 115826, 2023 | 4 | 2023 |
| Multistage in silico approach to identify novel quinoline derivatives as potential c-kit kinase inhibitors S Gupta, M Saha, R Singh, SB Ahmed, V Asati Journal of Biomolecular Structure and Dynamics, 1-18, 2024 | 1 | 2024 |
| Combined computational and synthetic strategies for the development of potent pyrazolo-pyridine derivatives as anticancer agents S Ayaz, S Gupta, R Singh, BD Kurmi, AA Almehizia, V Asati Journal of Molecular Structure 1311, 138301, 2024 | | 2024 |
| PIM kinase inhibitors: an updated patent review (2016-present) A Sharma, R Dubey, S Gupta, V Asati, V Kumar, D Kumar, DK Mahapatra, ... Expert Opinion on Therapeutic Patents, 2024 | | 2024 |
| Assessment of structural and activity-related contributions of various PIM-1 kinase inhibitors in the treatment of leukemia and prostate cancer A Sharma, R Dubey, V Asati, GS Baweja, S Gupta, V Asati Molecular Diversity, 1-33, 2024 | | 2024 |
| A comprehensive review of small molecules targeting PI3K pathway: Exploring the structural development for the treatment of breast cancer R Dubey, A Sharma, S Gupta, GD Gupta, V Asati Bioorganic Chemistry, 107077, 2023 | | 2023 |
| In silico studies for the identification of potential thiazolidine-2, 4-diones as _ampersandsignalpha;-amylase inhibitors K Dagar, S Gupta, A Singh, V Asati Pharmaspire 15, 48-53, 0 | | |
Vivek AsatiISF College of Pharmacy, Moga在 isfcp.org 的电子邮件经过验证
